Cargando…
Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study
OBJECTIVES: To describe neurodevelopment at age 5 among children born preterm. DESIGN: Population based cohort study, EPIPAGE-2. SETTING: France, 2011. PARTICIPANTS: 4441 children aged 5½ born at 24-26, 27-31, and 32-34 weeks MAIN OUTCOME MEASURES: Severe/moderate neurodevelopmental disabilities, de...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080137/ https://www.ncbi.nlm.nih.gov/pubmed/33910920 http://dx.doi.org/10.1136/bmj.n741 |
_version_ | 1783685366577889280 |
---|---|
author | Pierrat, Véronique Marchand-Martin, Laetitia Marret, Stéphane Arnaud, Catherine Benhammou, Valérie Cambonie, Gilles Debillon, Thierry Dufourg, Marie-Noëlle Gire, Catherine Goffinet, François Kaminski, Monique Lapillonne, Alexandre Morgan, Andrei Scott Rozé, Jean-Christophe Twilhaar, Sabrina Charles, Marie-Aline Ancel, Pierre-Yves Langer, Bruno Matis, Jacqueline Kuhn, Pierre Rebola, Muriel Renesme, Laurent Joly, Laurent Lecomte, Benedicte Datin-Dorriere, Valerie Guillois, Bernard Burguet, Antoine Semama, Denis Roué, Jean-Michel Bretaudeau, Gilles Rouget, Florence Saliba, Elie Favaris, Géraldine Bednarek, Nathalie Loron, Gauthier Thiriez, Gerard Chadie, Alexandra de la Villéon, Gaëlle Durrmeyer, Xavier Granier, Michèle Boileau, Pascal Kayem, Gilles Jarreau, Pierre-Henri Foix-L’Hélias, Laurence Boulot, Pierre Daudé, Hubert Bédu, Antoine Mons, Fabienne Deforge, Hélène Fresson, Jeanne Vayssière, Christophe Breinig, Sophie Truffert, Patrick Nuytten, Alexandra Charkaluk, Marie Laure Brevaut, Veronique Zahed, Meriem Garcia, Patricia Fayol, Laurence Flamant, Cyril Muller, Jean-Baptiste Gascoin, Géraldine Leke, André Fontaine, Cécile Claris, Olivier Picaud, Jean-Charles Ego, Anne Patural, Hughes Poulichet, Anne Abrial, Aude Favre, Anne Fléchelles, Olivier Ramful, Duksha Carbonnier, Magali Simeon, Thierry |
author_facet | Pierrat, Véronique Marchand-Martin, Laetitia Marret, Stéphane Arnaud, Catherine Benhammou, Valérie Cambonie, Gilles Debillon, Thierry Dufourg, Marie-Noëlle Gire, Catherine Goffinet, François Kaminski, Monique Lapillonne, Alexandre Morgan, Andrei Scott Rozé, Jean-Christophe Twilhaar, Sabrina Charles, Marie-Aline Ancel, Pierre-Yves Langer, Bruno Matis, Jacqueline Kuhn, Pierre Rebola, Muriel Renesme, Laurent Joly, Laurent Lecomte, Benedicte Datin-Dorriere, Valerie Guillois, Bernard Burguet, Antoine Semama, Denis Roué, Jean-Michel Bretaudeau, Gilles Rouget, Florence Saliba, Elie Favaris, Géraldine Bednarek, Nathalie Loron, Gauthier Thiriez, Gerard Chadie, Alexandra de la Villéon, Gaëlle Durrmeyer, Xavier Granier, Michèle Boileau, Pascal Kayem, Gilles Jarreau, Pierre-Henri Foix-L’Hélias, Laurence Boulot, Pierre Daudé, Hubert Bédu, Antoine Mons, Fabienne Deforge, Hélène Fresson, Jeanne Vayssière, Christophe Breinig, Sophie Truffert, Patrick Nuytten, Alexandra Charkaluk, Marie Laure Brevaut, Veronique Zahed, Meriem Garcia, Patricia Fayol, Laurence Flamant, Cyril Muller, Jean-Baptiste Gascoin, Géraldine Leke, André Fontaine, Cécile Claris, Olivier Picaud, Jean-Charles Ego, Anne Patural, Hughes Poulichet, Anne Abrial, Aude Favre, Anne Fléchelles, Olivier Ramful, Duksha Carbonnier, Magali Simeon, Thierry |
author_sort | Pierrat, Véronique |
collection | PubMed |
description | OBJECTIVES: To describe neurodevelopment at age 5 among children born preterm. DESIGN: Population based cohort study, EPIPAGE-2. SETTING: France, 2011. PARTICIPANTS: 4441 children aged 5½ born at 24-26, 27-31, and 32-34 weeks MAIN OUTCOME MEASURES: Severe/moderate neurodevelopmental disabilities, defined as severe/moderate cerebral palsy (Gross Motor Function Classification System (GMFCS) ≥2), or unilateral or bilateral blindness or deafness, or full scale intelligence quotient less than minus two standard deviations (Wechsler Preschool and Primary Scale of Intelligence, 4th edition). Mild neurodevelopmental disabilities, defined as mild cerebral palsy (GMFCS-1), or visual disability ≥3.2/10 and <5/10, or hearing loss <40 dB, or full scale intelligence quotient (minus two to minus one standard deviation) or developmental coordination disorders (Movement Assessment Battery for Children, 2nd edition, total score less than or equal to the fifth centile), or behavioural difficulties (strengths and difficulties questionnaire, total score greater than or equal to the 90th centile), school assistance (mainstream class with support or special school), complex developmental interventions, and parents’ concerns about development. The distributions of the scores in contemporary term born children were used as reference. Results are given after multiple imputation as percentages of outcome measures with exact binomial 95% confidence intervals. RESULTS: Among 4441 participants, 3083 (69.4%) children were assessed. Rates of severe/moderate neurodevelopmental disabilities were 28% (95% confidence interval 23.4% to 32.2%), 19% (16.8% to 20.7%), and 12% (9.2% to 14.0%) and of mild disabilities were 38.5% (33.7% to 43.4%), 36% (33.4% to 38.1%), and 34% (30.2% to 37.4%) at 24-26, 27-31, and 32-34 weeks, respectively. Assistance at school was used by 27% (22.9% to 31.7%), 14% (12.1% to 15.9%), and 7% (4.4% to 9.0%) of children at 24-26, 27-31, and 32-34 weeks, respectively. About half of the children born at 24-26 weeks (52% (46.4% to 57.3%)) received at least one developmental intervention which decreased to 26% (21.8% to 29.4%) for those born at 32-34 weeks. Behaviour was the concern most commonly reported by parents. Rates of neurodevelopment disabilities increased as gestational age decreased and were higher in families with low socioeconomic status. CONCLUSIONS: In this large cohort of children born preterm, rates of severe/moderate neurodevelopmental disabilities remained high in each gestational age group. Proportions of children receiving school assistance or complex developmental interventions might have a significant impact on educational and health organisations. Parental concerns about behaviour warrant attention. |
format | Online Article Text |
id | pubmed-8080137 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80801372021-05-12 Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study Pierrat, Véronique Marchand-Martin, Laetitia Marret, Stéphane Arnaud, Catherine Benhammou, Valérie Cambonie, Gilles Debillon, Thierry Dufourg, Marie-Noëlle Gire, Catherine Goffinet, François Kaminski, Monique Lapillonne, Alexandre Morgan, Andrei Scott Rozé, Jean-Christophe Twilhaar, Sabrina Charles, Marie-Aline Ancel, Pierre-Yves Langer, Bruno Matis, Jacqueline Kuhn, Pierre Rebola, Muriel Renesme, Laurent Joly, Laurent Lecomte, Benedicte Datin-Dorriere, Valerie Guillois, Bernard Burguet, Antoine Semama, Denis Roué, Jean-Michel Bretaudeau, Gilles Rouget, Florence Saliba, Elie Favaris, Géraldine Bednarek, Nathalie Loron, Gauthier Thiriez, Gerard Chadie, Alexandra de la Villéon, Gaëlle Durrmeyer, Xavier Granier, Michèle Boileau, Pascal Kayem, Gilles Jarreau, Pierre-Henri Foix-L’Hélias, Laurence Boulot, Pierre Daudé, Hubert Bédu, Antoine Mons, Fabienne Deforge, Hélène Fresson, Jeanne Vayssière, Christophe Breinig, Sophie Truffert, Patrick Nuytten, Alexandra Charkaluk, Marie Laure Brevaut, Veronique Zahed, Meriem Garcia, Patricia Fayol, Laurence Flamant, Cyril Muller, Jean-Baptiste Gascoin, Géraldine Leke, André Fontaine, Cécile Claris, Olivier Picaud, Jean-Charles Ego, Anne Patural, Hughes Poulichet, Anne Abrial, Aude Favre, Anne Fléchelles, Olivier Ramful, Duksha Carbonnier, Magali Simeon, Thierry BMJ Research OBJECTIVES: To describe neurodevelopment at age 5 among children born preterm. DESIGN: Population based cohort study, EPIPAGE-2. SETTING: France, 2011. PARTICIPANTS: 4441 children aged 5½ born at 24-26, 27-31, and 32-34 weeks MAIN OUTCOME MEASURES: Severe/moderate neurodevelopmental disabilities, defined as severe/moderate cerebral palsy (Gross Motor Function Classification System (GMFCS) ≥2), or unilateral or bilateral blindness or deafness, or full scale intelligence quotient less than minus two standard deviations (Wechsler Preschool and Primary Scale of Intelligence, 4th edition). Mild neurodevelopmental disabilities, defined as mild cerebral palsy (GMFCS-1), or visual disability ≥3.2/10 and <5/10, or hearing loss <40 dB, or full scale intelligence quotient (minus two to minus one standard deviation) or developmental coordination disorders (Movement Assessment Battery for Children, 2nd edition, total score less than or equal to the fifth centile), or behavioural difficulties (strengths and difficulties questionnaire, total score greater than or equal to the 90th centile), school assistance (mainstream class with support or special school), complex developmental interventions, and parents’ concerns about development. The distributions of the scores in contemporary term born children were used as reference. Results are given after multiple imputation as percentages of outcome measures with exact binomial 95% confidence intervals. RESULTS: Among 4441 participants, 3083 (69.4%) children were assessed. Rates of severe/moderate neurodevelopmental disabilities were 28% (95% confidence interval 23.4% to 32.2%), 19% (16.8% to 20.7%), and 12% (9.2% to 14.0%) and of mild disabilities were 38.5% (33.7% to 43.4%), 36% (33.4% to 38.1%), and 34% (30.2% to 37.4%) at 24-26, 27-31, and 32-34 weeks, respectively. Assistance at school was used by 27% (22.9% to 31.7%), 14% (12.1% to 15.9%), and 7% (4.4% to 9.0%) of children at 24-26, 27-31, and 32-34 weeks, respectively. About half of the children born at 24-26 weeks (52% (46.4% to 57.3%)) received at least one developmental intervention which decreased to 26% (21.8% to 29.4%) for those born at 32-34 weeks. Behaviour was the concern most commonly reported by parents. Rates of neurodevelopment disabilities increased as gestational age decreased and were higher in families with low socioeconomic status. CONCLUSIONS: In this large cohort of children born preterm, rates of severe/moderate neurodevelopmental disabilities remained high in each gestational age group. Proportions of children receiving school assistance or complex developmental interventions might have a significant impact on educational and health organisations. Parental concerns about behaviour warrant attention. BMJ Publishing Group Ltd. 2021-04-28 /pmc/articles/PMC8080137/ /pubmed/33910920 http://dx.doi.org/10.1136/bmj.n741 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Research Pierrat, Véronique Marchand-Martin, Laetitia Marret, Stéphane Arnaud, Catherine Benhammou, Valérie Cambonie, Gilles Debillon, Thierry Dufourg, Marie-Noëlle Gire, Catherine Goffinet, François Kaminski, Monique Lapillonne, Alexandre Morgan, Andrei Scott Rozé, Jean-Christophe Twilhaar, Sabrina Charles, Marie-Aline Ancel, Pierre-Yves Langer, Bruno Matis, Jacqueline Kuhn, Pierre Rebola, Muriel Renesme, Laurent Joly, Laurent Lecomte, Benedicte Datin-Dorriere, Valerie Guillois, Bernard Burguet, Antoine Semama, Denis Roué, Jean-Michel Bretaudeau, Gilles Rouget, Florence Saliba, Elie Favaris, Géraldine Bednarek, Nathalie Loron, Gauthier Thiriez, Gerard Chadie, Alexandra de la Villéon, Gaëlle Durrmeyer, Xavier Granier, Michèle Boileau, Pascal Kayem, Gilles Jarreau, Pierre-Henri Foix-L’Hélias, Laurence Boulot, Pierre Daudé, Hubert Bédu, Antoine Mons, Fabienne Deforge, Hélène Fresson, Jeanne Vayssière, Christophe Breinig, Sophie Truffert, Patrick Nuytten, Alexandra Charkaluk, Marie Laure Brevaut, Veronique Zahed, Meriem Garcia, Patricia Fayol, Laurence Flamant, Cyril Muller, Jean-Baptiste Gascoin, Géraldine Leke, André Fontaine, Cécile Claris, Olivier Picaud, Jean-Charles Ego, Anne Patural, Hughes Poulichet, Anne Abrial, Aude Favre, Anne Fléchelles, Olivier Ramful, Duksha Carbonnier, Magali Simeon, Thierry Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study |
title | Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study |
title_full | Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study |
title_fullStr | Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study |
title_full_unstemmed | Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study |
title_short | Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study |
title_sort | neurodevelopmental outcomes at age 5 among children born preterm: epipage-2 cohort study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080137/ https://www.ncbi.nlm.nih.gov/pubmed/33910920 http://dx.doi.org/10.1136/bmj.n741 |
work_keys_str_mv | AT pierratveronique neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT marchandmartinlaetitia neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT marretstephane neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT arnaudcatherine neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT benhammouvalerie neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT camboniegilles neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT debillonthierry neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT dufourgmarienoelle neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT girecatherine neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT goffinetfrancois neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT kaminskimonique neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT lapillonnealexandre neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT morganandreiscott neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT rozejeanchristophe neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT twilhaarsabrina neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT charlesmariealine neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT ancelpierreyves neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT langerbruno neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT matisjacqueline neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT kuhnpierre neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT rebolamuriel neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT renesmelaurent neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT jolylaurent neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT lecomtebenedicte neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT datindorrierevalerie neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT guilloisbernard neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT burguetantoine neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT semamadenis neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT rouejeanmichel neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT bretaudeaugilles neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT rougetflorence neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT salibaelie neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT favarisgeraldine neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT bednareknathalie neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT lorongauthier neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT thiriezgerard neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT chadiealexandra neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT delavilleongaelle neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT durrmeyerxavier neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT graniermichele neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT boileaupascal neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT kayemgilles neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT jarreaupierrehenri neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT foixlheliaslaurence neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT boulotpierre neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT daudehubert neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT beduantoine neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT monsfabienne neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT deforgehelene neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT fressonjeanne neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT vayssierechristophe neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT breinigsophie neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT truffertpatrick neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT nuyttenalexandra neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT charkalukmarielaure neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT brevautveronique neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT zahedmeriem neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT garciapatricia neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT fayollaurence neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT flamantcyril neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT mullerjeanbaptiste neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT gascoingeraldine neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT lekeandre neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT fontainececile neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT clarisolivier neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT picaudjeancharles neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT egoanne neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT paturalhughes neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT poulichetanne neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT abrialaude neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT favreanne neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT flechellesolivier neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT ramfulduksha neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT carbonniermagali neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy AT simeonthierry neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy |